Investigating the role of itaconate in macrophage activation and oxidative stress injury in sepsis-associated acute kidney injury
- PMID: 38642169
- DOI: 10.1007/s11033-024-09462-0
Investigating the role of itaconate in macrophage activation and oxidative stress injury in sepsis-associated acute kidney injury
Abstract
Background: Sepsis may be linked to oxidative stress and can be controlled by itaconate, an activator of the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway. Nevertheless, the itaconate impact on sepsis-associated acute kidney injury (SA-AKI) has yet to be definitively established.
Methods: We employed SA-AKI mouse model through a cecal ligation and puncture (CLP) procedure for the in vivo investigation of the potential nephroprotective effect of itaconate in this study. A plasmid was transfected into RAW264.7 cells to examine the Nrf2 pathway function after itaconate administration. Finally, the immune-responsive gene 1-knockout (IRG1-/-) mice were used to study the itaconate impacts on oxidative stress-induced SA-AKI.
Results: We have shown that 4-octyl itaconate (OI) significantly reduced CD11b-positive macrophage aggregation and activated the Nrf2 pathway in the bone marrow-derived macrophages (BMDM). The impacts of Nrf2 inhibitor ML385 on the anti-inflammatory and antioxidant properties of itaconate were found to be partial. OI inhibited lipopolysaccharide-induced oxidative stress injury in RAW264.7 macrophages and activated Nrf2 in the nucleus to hinder the expression of nuclear factor kappa B p65, thereby suppressing oxidative stress injury in the macrophages. Additionally, the introduction of the transfected plasmid resulted in a partial inhibition of the anti-inflammatory impact of itaconate. The kidney injury caused by sepsis exhibited greater severity in the IRG1-/- mice than in the wild type mice. Exogenous OI partially attenuated the kidney injury induced by sepsis in the IRG1-/- mice and suppressed the oxidative stress injury in macrophages.
Conclusions: This investigation offers new proof to support the itaconate function in the development and progression of SA-AKI and shows a new possible therapeutic agent for the SA-AKI treatment.
Keywords: Acute kidney injury; Itaconate; Nrf2; Oxidative stress; Sepsis.
© 2024. The Author(s), under exclusive licence to Springer Nature B.V.
Similar articles
-
4-Octyl itaconate attenuates LPS-induced acute kidney injury by activating Nrf2 and inhibiting STAT3 signaling.Mol Med. 2023 Apr 24;29(1):58. doi: 10.1186/s10020-023-00631-8. Mol Med. 2023. PMID: 37095432 Free PMC article.
-
IRG1/itaconate alleviates acute liver injury in septic mice by suppressing NLRP3 expression and its mediated macrophage pyroptosis via regulation of the Nrf2 pathway.Int Immunopharmacol. 2024 Jun 30;135:112277. doi: 10.1016/j.intimp.2024.112277. Epub 2024 May 23. Int Immunopharmacol. 2024. PMID: 38788445
-
Pharmacological inhibition of STING-mediated GPX4 autophagic degradation by 4-octyl itaconate ameliorates sepsis-induced acute kidney injury.Apoptosis. 2025 Jun;30(5-6):1410-1423. doi: 10.1007/s10495-025-02099-9. Epub 2025 Mar 22. Apoptosis. 2025. PMID: 40119983
-
Itaconate: an emerging determinant of inflammation in activated macrophages.Immunol Cell Biol. 2019 Feb;97(2):134-141. doi: 10.1111/imcb.12218. Epub 2018 Dec 11. Immunol Cell Biol. 2019. PMID: 30428148 Review.
-
Metabolic Regulation of Inflammation: Exploring the Potential Benefits of Itaconate in Autoimmune Disorders.Immunology. 2025 Feb;174(2):189-202. doi: 10.1111/imm.13875. Epub 2024 Nov 14. Immunology. 2025. PMID: 39542834 Review.
Cited by
-
Itaconic Acid: A Regulator of Immune Responses and Inflammatory Metabolism.Curr Issues Mol Biol. 2025 Jul 9;47(7):534. doi: 10.3390/cimb47070534. Curr Issues Mol Biol. 2025. PMID: 40729001 Free PMC article. Review.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous